As of December 2024 Inozyme Pharma has a market cap of A$0.30 Billion. This makes Inozyme Pharma the world's 8148th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Dec 22nd, 2024 the market cap of Inozyme Pharma was reported to be: